Oculis Holding AG (OCS) Operating Income (2022 - 2026)
Oculis Holding AG (OCS) recorded Operating Income of $392,224 in Q2 2026, up 24.4% from $315,259 a year earlier and up 47.0% from the prior quarter.
Powered by 
Analysis
Oculis Holding AG (OCS) Operating Income (2022 - 2026) Analysis & Trends
On a TTM basis, Oculis Holding AG's Operating Income came in at $1.48 million as of Jun 30, 2026, up 66.9% year-over-year; for FY2025, it was $1.5 million, up 92.4% from FY2024.
- Annual Operating Income has a five-year compound annual growth rate of 7.2% (FY2020 to FY2025).
- Across earlier years, Operating Income came in at $779,777 in FY2024 (-21.7%), $995,454 in FY2023 (+4.1%), $956,035 in FY2022 (-9.0%) and $1.05 million in FY2021 (-0.8%).
- Quarterly Operating Income has ranged from $3,425 in Q4 2024 to $514,231 in Q4 2025 over the past five years.
- On a year-over-year basis, Operating Income rose in five of the last seven quarters, with an average decline of 3.8%.
- Peak year-over-year performance for Operating Income in the last five years was growth of 24.6% in Q1 2025, against a decline of 98.4% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $266,894 (Q1 2026), $514,231 (Q4 2025) and $303,777 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Oculis Holding AG | 476.98 Mn | 476.98 Mn | - | 392,224.12 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 392,224.12 |
| Mar 31, 2026 | 266,893.98 |
| Dec 31, 2025 | 514,230.78 |
| Sep 30, 2025 | 303,776.61 |
| Jun 30, 2025 | 315,259.35 |
| Mar 31, 2025 | 316,991.40 |
| Dec 31, 2024 | 3,424.57 |
| Sep 30, 2024 | 249,308.76 |
| Jun 30, 2024 | 270,919.40 |
| Mar 31, 2024 | 254,341.47 |
| Dec 31, 2023 | 208,560.58 |
| Sep 30, 2023 | 247,941.41 |
| Jun 30, 2023 | 278,043.89 |
| Mar 31, 2023 | 247,586.23 |
| Dec 31, 2022 | 222,136.69 |
| Sep 30, 2022 | 209,162.24 |
| Jun 30, 2022 | 265,803.01 |
API Access
Oculis Holding AG Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=OCS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "OCS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=OCS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();